Lujun Shen

1.8k total citations
95 papers, 1.2k citations indexed

About

Lujun Shen is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lujun Shen has authored 95 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hepatology, 29 papers in Oncology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lujun Shen's work include Hepatocellular Carcinoma Treatment and Prognosis (41 papers), Liver Disease Diagnosis and Treatment (17 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers). Lujun Shen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (41 papers), Liver Disease Diagnosis and Treatment (17 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers). Lujun Shen collaborates with scholars based in China, United States and Japan. Lujun Shen's co-authors include Peihong Wu, Qifeng Chen, Wang Li, Tao Huang, Weijun Fan, Shuanggang Chen, Boyang Chang, Zilin Huang, Han Qi and Ying Wu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lujun Shen

85 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lujun Shen China	20	408	372	358	306	258	95	1.2k
Lie Zheng China	17	387 0.9×	579 1.6×	157 0.4×	254 0.8×	151 0.6×	70	1.3k
Weikai Xiao China	18	477 1.2×	213 0.6×	425 1.2×	265 0.9×	473 1.8×	37	1.1k
Tongyu Lin China	17	484 1.2×	230 0.6×	216 0.6×	139 0.5×	108 0.4×	71	1.1k
Hubing Wu China	21	493 1.2×	138 0.4×	162 0.5×	338 1.1×	272 1.1×	100	1.4k
Ruhai Zou China	19	247 0.6×	783 2.1×	176 0.5×	212 0.7×	241 0.9×	45	1.3k
Skye Hongiun Cheng Taiwan	23	562 1.4×	410 1.1×	269 0.8×	420 1.4×	382 1.5×	32	1.7k
He Huang China	19	480 1.2×	217 0.6×	537 1.5×	159 0.5×	297 1.2×	78	1.4k
Cécile Charpy France	13	661 1.6×	287 0.8×	209 0.6×	262 0.9×	194 0.8×	29	1.2k
Xia Yang China	24	429 1.1×	218 0.6×	389 1.1×	821 2.7×	196 0.8×	94	1.6k
Yoshitaka Honma Japan	22	952 2.3×	121 0.3×	878 2.5×	776 2.5×	674 2.6×	170	2.3k

Countries citing papers authored by Lujun Shen

Since Specialization

Citations

This map shows the geographic impact of Lujun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lujun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lujun Shen more than expected).

Fields of papers citing papers by Lujun Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lujun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lujun Shen. The network helps show where Lujun Shen may publish in the future.

Co-authorship network of co-authors of Lujun Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Lujun Shen. A scholar is included among the top collaborators of Lujun Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lujun Shen. Lujun Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Lujun, et al.. (2025). Analyzing performance fluctuations in flat lenses due to feature structure distortion using a differential profile parsing method. Optics Express. 33(4). 8862–8862.

Chen, Shuanggang, Lujun Shen, Boyang Chang, et al.. (2025). Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study. International Journal of Surgery. 111(12). 9411–9420.

Sun, Zehua, et al.. (2025). The Research on Multi-Process Collaborative Manufacturing and Characterization Methods of Micro–Nano-Composite Layered Structures. Nanomaterials. 15(22). 1716–1716.

Jiang, Yiquan, Lujun Shen, Ling Gu, et al.. (2024). Cryoablation-induced neutrophil Ca2+ elevation and NET formation exacerbate immune escape in colorectal cancer liver metastasis. Journal of Experimental & Clinical Cancer Research. 43(1). 319–319. 5 indexed citations

Shen, Lujun, Jia‐Tao Zhang, Jian Xu, et al.. (2024). Survival path model outperforms conventional static machine learning models in long-term dynamic prognosis prediction for patients with intermediate stage hepatocellular carcinoma. Bioinformatics Advances. 5(1). vbaf027–vbaf027.

Shen, Lujun, Yiquan Jiang, Jia‐Tao Zhang, et al.. (2024). Machine Learning for Dynamic Prognostication of Patients With Hepatocellular Carcinoma Using Time-Series Data: Survival Path Versus Dynamic-DeepHit HCC Model. Cancer Informatics. 23. 2683916279–2683916279.

Shen, Lujun, Juan Nie, Yiquan Jiang, et al.. (2024). Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma receiving PD-1 blockade therapy. Cancer Immunology Immunotherapy. 73(4). 68–68. 5 indexed citations

Shen, Lujun, Changsheng Yang, Yiquan Jiang, et al.. (2023). SurvivalPath:A R package for conducting personalized survival path mapping based on time-series survival data. PLoS Computational Biology. 19(1). e1010830–e1010830. 6 indexed citations

Chen, Shuanggang, Ying Wu, Lujun Shen, et al.. (2023). The relationship between the efficacy of thermal ablation and inflammatory response and immune status in early hepatocellular carcinoma and the progress of postoperative adjuvant therapy. International Immunopharmacology. 119. 110228–110228. 3 indexed citations

10.

Shen, Lujun, Ying Wu, Han Qi, et al.. (2022). Inducible Regulatory T Cell Predicts Efficacy of PD‐1 Blockade Therapy in Melanoma. Advanced Therapeutics. 5(4). 2 indexed citations

11.

Shen, Lujun, et al.. (2022). Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study. EClinicalMedicine. 47. 101391–101391. 19 indexed citations

12.

Jiang, Yiquan, Zixian Wang, Ming Zhong, et al.. (2021). Investigating Mechanisms of Response or Resistance to Immune Checkpoint Inhibitors by Analyzing Cell-Cell Communications in Tumors Before and After Programmed Cell Death-1 (PD-1) Targeted Therapy: An Integrative Analysis Using Single-cell RNA and Bulk-RNA Sequencing Data. OncoImmunology. 10(1). 1908010–1908010. 26 indexed citations

13.

Que, Yi, Xiao-Long Zhang, Zexian Liu, et al.. (2021). Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma. Journal for ImmunoTherapy of Cancer. 9(2). e001696–e001696. 67 indexed citations

14.

Yuan, Hui, et al.. (2021). Value of low-dose and optimized-length computed tomography (CT) scan in CT-guided percutaneous transthoracic needle biopsy of pulmonary nodules. SHILAP Revista de lepidopterología. 4(3). 143–148. 4 indexed citations

15.

Shen, Lujun, et al.. (2020). Calculations of Bethe logarithm for hydrogen and helium using B-splines in different gauges. Journal of Physics B Atomic Molecular and Optical Physics. 53(13). 135003–135003. 2 indexed citations

16.

Li, Wang, et al.. (2020). Bioinformatic analysis and in vitro validation of a five-microRNA signature as a prognostic biomarker of hepatocellular carcinoma. Annals of Translational Medicine. 8(21). 1422–1422. 5 indexed citations

17.

Chen, Shuanggang, Lujun Shen, Zhiyu Qiu, et al.. (2020). Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma. Journal of Cancer Research and Therapeutics. 16(2). 250–257. 8 indexed citations

18.

Chen, Qifeng, et al.. (2019). Predictive value of a nomogram for hepatocellular carcinoma with brain metastasis at initial diagnosis: A population-based study. PLoS ONE. 14(1). e0209293–e0209293. 15 indexed citations

19.

Li, Sheng, et al.. (2016). Percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic–pathologic correlation in an animal study. Journal of Translational Medicine. 14(1). 238–238. 9 indexed citations

20.

Chen, Chen, Yi Wei, Jin Gao, et al.. (2014). Alternative endpoints to the 5-year overall survival and locoregional control for nasopharyngeal carcinoma: A retrospective analysis of 2,450 patients. Molecular and Clinical Oncology. 2(3). 385–392. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact